News|Articles|December 3, 2025
Digital Expression Control with GPEx® Lightning: Enabling Complex Biologics in CHO Cells
Author(s)Catalent
This scientific poster showcases how GPEx® Lightning enables precise, digital control of gene expression for complex biologics. By leveraging targeted integration into ~200 Dock sites and a single optimized construct, developers can fine-tune gene ratios for co-expression of enzymes, cofactors, and multi-chain proteins. Learn how this approach streamlines screening, boosts titers, and shortens timelines—even for products with unknown stoichiometry.
Newsletter
Get the essential updates shaping the future of pharma manufacturing and compliance—subscribe today to Pharmaceutical Technology and never miss a breakthrough.
Related Content
Trending on Pharmaceutical Technology
1
Lilly Launches UK Trial of Weight-Loss Drug as US Price Drops
2
BirchBioMed’s Idiopathic Pulmonary Fibrosis Treatment Receives Orphan Drug Designation
3
Batch Certification for New Manufacturing Technologies: The Qualified Person Role in a Digital Environment
4
FDA Deploys Agentic AI Capabilities for Agency Staff
5
